Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

1,124 companies

Ticker	Company	Revenue	Net income	Net margin ▴	Return on equity	Revenue growth	Diluted EPS
AEMD	Aethlon Medical Inc Manufacturing · Year ended 2026-03-31 · USD	n/a	-$7.15M	n/a	-146.4%	n/a	-$10.61
AERG	Applied Energetics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$461.7K	-$14.87M	n/m	-196.7%	-81.0%	-$0.07
AGPU	Axe Compute Inc. Finance & Real Estate · Year ended 2025-12-31 · USD	$125.3K	-$233.10M	n/m	-488.5%	47.7%	n/a
AGQ	ProShares Trust II Finance & Real Estate · Year ended 2025-12-31 · USD	n/a	$1.71B	n/a	29.9%	n/a	n/a
AIFC	AI Financial Corp Finance & Real Estate · Year ended 2025-12-27 · USD	$24.84M	-$344.66M	n/m	-29.9%	109.0%	-$5.91
AIFF	Firefly Neuroscience, Inc. Services · Year ended 2025-12-31 · USD	$1.14M	-$19.88M	n/m	-260.3%	957.4%	n/a
AIIA	AI Infrastructure Acquisition Corp. Finance & Real Estate · Year ended 2025-12-31 · USD	n/a	n/a	n/a	n/a	n/a	n/a
AIOS	AIOS Tech Inc. Manufacturing · Year ended 2025-12-31 · USD	$5.07M	-$220.91M	n/m	n/m	-98.5%	-$47.65
AIRJ	AirJoule Technologies Corp. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$9.04M	n/a	-3.4%	n/a	n/a
ALDF	Aldel Financial II Inc. Finance & Real Estate · Year ended 2025-12-31 · USD	n/a	$9.23M	n/a	n/m	n/a	n/a
ALIS	Calisa Acquisition Corp Services · Year ended 2025-12-31 · USD	n/a	$245.5K	n/a	48.8%	n/a	n/a
ALLO	Allogene Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$190.89M	n/a	-65.3%	-100.0%	-$0.87
ALMS	Alumis Inc. Manufacturing · Year ended 2025-12-31 · USD	$24.05M	-$243.32M	n/m	-80.8%	n/a	-$2.86
ALT	Altimmune, Inc. Manufacturing · Year ended 2025-12-31 · USD	$41.0K	-$88.09M	n/m	-39.2%	105.0%	-$1.00
AMIX	Autonomix Medical, Inc. Manufacturing · Year ended 2026-03-31 · USD	$0	-$16.71M	n/a	-283.5%	n/a	n/a
AMLX	Amylyx Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$144.74M	n/a	-47.4%	-100.0%	-$1.53
AMTD	Amtd Idea Group Finance & Real Estate · Year ended 2025-12-31 · USD	n/a	$67.25M	n/a	4.9%	n/a	n/a
ANEB	Anebulo Pharmaceuticals, Inc. Manufacturing · Year ended 2025-06-30 · USD	n/a	-$8.48M	n/a	-72.8%	n/a	-$0.25
ANIX	Anixa Biosciences Inc Manufacturing · Year ended 2025-10-31 · USD	n/a	-$10.93M	n/a	-72.1%	n/a	-$0.34
ANNX	Annexon, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$206.69M	n/a	-97.7%	n/a	-$1.34
ANRO	Alto Neuroscience, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$63.24M	n/a	-41.8%	n/a	-$2.19
ANTX	AN2 Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$35.17M	n/a	-66.3%	n/a	-$1.16
ANVS	Annovis Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$28.85M	n/a	-171.2%	n/a	-$1.40
AOXY	Advanced Oxygen Technologies Inc Finance & Real Estate · Year ended 2026-06-30 · USD	n/a	$103.0K	n/a	20.9%	n/a	$0.03
APAC	StoneBridge Acquisition II Corp Finance & Real Estate · Year ended 2025-12-31 · USD	n/a	$302.3K	n/a	55.5%	n/a	n/a

Rows per page: 2550 100